<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001017</url>
  </required_header>
  <id_info>
    <org_study_id>ACTG 026</org_study_id>
    <secondary_id>056-158</secondary_id>
    <secondary_id>FDA 12E</secondary_id>
    <nct_id>NCT00001017</nct_id>
  </id_info>
  <brief_title>Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS</brief_title>
  <official_title>Comparison of Fluconazole (UK-49,858) and Amphotericin B for Maintenance Treatment of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of Allergy and Infectious Diseases (NIAID)</source>
  <brief_summary>
    <textblock>
      To compare the safety and effectiveness of a new drug, fluconazole, with that of the usual&#xD;
      therapy, amphotericin B, in the prevention of a relapse of cryptococcal meningitis (CM) in&#xD;
      patients with AIDS who have been successfully treated for acute CM in the last 6 months.&#xD;
&#xD;
      Cryptococcal meningitis is a life-threatening infectious complication of AIDS. Because&#xD;
      relapse after treatment occurs in over 50 percent of cases, chronic maintenance therapy with&#xD;
      intravenous (IV) amphotericin B is usually given. However, amphotericin B is not always&#xD;
      effective, has toxic effects, and must be given by the intravenous route. Fluconazole is an&#xD;
      antifungal agent that can be given orally and has been shown to be effective against&#xD;
      cryptococcal infections in animals and against acute CM in a few AIDS patients. Also, the&#xD;
      side effects experienced by over 2000 patients or volunteers given fluconazole have seldom&#xD;
      been severe enough to require withdrawal of the drug.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cryptococcal meningitis is a life-threatening infectious complication of AIDS. Because&#xD;
      relapse after treatment occurs in over 50 percent of cases, chronic maintenance therapy with&#xD;
      intravenous (IV) amphotericin B is usually given. However, amphotericin B is not always&#xD;
      effective, has toxic effects, and must be given by the intravenous route. Fluconazole is an&#xD;
      antifungal agent that can be given orally and has been shown to be effective against&#xD;
      cryptococcal infections in animals and against acute CM in a few AIDS patients. Also, the&#xD;
      side effects experienced by over 2000 patients or volunteers given fluconazole have seldom&#xD;
      been severe enough to require withdrawal of the drug.&#xD;
&#xD;
      Patients accepted in the trial are randomly assigned to fluconazole or amphotericin B.&#xD;
      Fluconazole is given orally once a day and amphotericin B is given intravenously once a week.&#xD;
      Dosages depend on body weight. Medications may be given with amphotericin B to prevent or&#xD;
      reduce discomfort from associated side effects. Patients are treated for 12 months and may&#xD;
      continue to receive antiviral therapy, radiation therapy for mucocutaneous Kaposi's sarcoma,&#xD;
      or preventive therapy for Pneumocystis carinii pneumonia (PCP) during the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <primary_completion_date type="Actual">July 1991</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment>330</enrollment>
  <condition>Meningitis, Cryptococcal</condition>
  <condition>HIV Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluconazole</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amphotericin B</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  HIV infection documented by antibody (ELISA on two occasions or ELISA with Western&#xD;
             blot confirmation), p24 antigen testing, or recovery of HIV in culture.&#xD;
&#xD;
        Prior Medication:&#xD;
&#xD;
        Required:&#xD;
&#xD;
          -  Minimum total dose of 15 mg/kg of amphotericin B (either alone or in combination with&#xD;
             flucytosine) during primary therapy. End of primary therapy within 6 weeks of start of&#xD;
             maintenance therapy.&#xD;
&#xD;
          -  Allowed:&#xD;
&#xD;
          -  Past or present antiviral therapy and prophylaxis for Pneumocystis carinii pneumonia&#xD;
             (PCP).&#xD;
&#xD;
          -  Pfizer must be notified if the patient is receiving ganciclovir at entry. Allowed with&#xD;
             amphotericin B to treat or prevent side effects.&#xD;
&#xD;
          -  Antipyretics.&#xD;
&#xD;
          -  Hydrocortisone.&#xD;
&#xD;
          -  Meperidine.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        Co-existing Condition:&#xD;
&#xD;
        Patients with the following are excluded:&#xD;
&#xD;
          -  Clinical evidence of acute or chronic meningitis other than cryptococcosis.&#xD;
&#xD;
          -  Allergy or intolerance of imidazoles, azoles, or amphotericin B. Unable to take oral&#xD;
             medications reliably.&#xD;
&#xD;
        Patients with the following are excluded:&#xD;
&#xD;
          -  Clinical evidence of acute or chronic meningitis other than cryptococcosis.&#xD;
&#xD;
          -  Allergy or intolerance of imidazoles, azoles, or amphotericin B.&#xD;
&#xD;
        Prior Medication:&#xD;
&#xD;
        Excluded for more than 7 days after initiation of primary therapy for cryptococcosis:&#xD;
&#xD;
          -  Ketoconazole.&#xD;
&#xD;
          -  Fluconazole.&#xD;
&#xD;
          -  Itraconazole.&#xD;
&#xD;
          -  Miconazole.&#xD;
&#xD;
          -  Any other systemic imidazole or azole.&#xD;
&#xD;
          -  Excluded:&#xD;
&#xD;
          -  Intrathecal amphotericin B.&#xD;
&#xD;
          -  Coumadin-type anticoagulants.&#xD;
&#xD;
          -  Oral hypoglycemics.&#xD;
&#xD;
          -  Barbiturates.&#xD;
&#xD;
          -  Phenytoin.&#xD;
&#xD;
          -  Immunostimulants.&#xD;
&#xD;
          -  Investigational drug or approved (licensed) drugs for investigational indications.&#xD;
&#xD;
        Prior Treatment:&#xD;
&#xD;
        Excluded:&#xD;
&#xD;
          -  Lymphocyte replacement.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Armstrong D</last_name>
    <role>Study Chair</role>
  </overall_official>
  <overall_official>
    <last_name>Dismukes W</last_name>
    <role>Study Chair</role>
  </overall_official>
  <overall_official>
    <last_name>Powderly W</last_name>
    <role>Study Chair</role>
  </overall_official>
  <location>
    <facility>
      <name>UCLA CARE Ctr</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ of Miami School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>331361013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana Univ Hosp</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>462025250</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Louisiana State Univ School of Medicine</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tulane Univ School of Medicine</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hosp</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harvard (Massachusetts Gen Hosp)</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess - West Campus</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jack Weiler Hosp / Bronx Municipal Hosp</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10465</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Med Ctr / Bronx Municipal Hosp</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Central Bronx Hosp / Bronx Municipal Hosp</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bronx Veterans Administration / Mount Sinai Hosp</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10468</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY / Erie County Med Ctr at Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Hosp Ctr at Elmhurst / Mount Sinai Hosp</name>
      <address>
        <city>Elmhurst</city>
        <state>New York</state>
        <zip>11373</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Med Ctr / Peter Krueger Clinic</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bellevue Hosp / New York Univ Med Ctr</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cornell Univ Med Ctr</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mem Sloan - Kettering Cancer Ctr</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's - Roosevelt Hosp Ctr</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Med Ctr</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY - Stony Brook</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>117948153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>275997215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke Univ Med Ctr</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holmes Hosp / Univ of Cincinnati Med Ctr</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>452670405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ Hosp of Cleveland / Case Western Reserve Univ</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State Univ Hosp Clinic</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>432101228</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Julio Arroyo</name>
      <address>
        <city>West Columbia</city>
        <state>South Carolina</state>
        <zip>29169</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med. 1992 Jan 9;326(2):83-9. doi: 10.1056/NEJM199201093260202.</citation>
    <PMID>1727236</PMID>
  </reference>
  <reference>
    <citation>Powderly WG, Saag MS, Cloud GA, Robinson P, Meyer RD, Jacobson JM, Graybill JR, Sugar AM, McAuliffe VJ, Follansbee SE, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med. 1992 Mar 19;326(12):793-8. doi: 10.1056/NEJM199203193261203.</citation>
    <PMID>1538722</PMID>
  </reference>
  <reference>
    <citation>Powderly WG, Cloud GA, Dismukes WE, Saag MS. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1994 May;18(5):789-92. doi: 10.1093/clinids/18.5.789.</citation>
    <PMID>8075272</PMID>
  </reference>
  <reference>
    <citation>McKinney RE Jr, Maha MA, Connor EM, Feinberg J, Scott GB, Wulfsohn M, McIntosh K, Borkowsky W, Modlin JF, Weintrub P, et al. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. N Engl J Med. 1991 Apr 11;324(15):1018-25. doi: 10.1056/NEJM199104113241503.</citation>
    <PMID>1672443</PMID>
  </reference>
  <verification_date>September 2002</verification_date>
  <study_first_submitted>November 2, 1999</study_first_submitted>
  <study_first_submitted_qc>August 30, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2001</study_first_posted>
  <last_update_submitted>March 11, 2011</last_update_submitted>
  <last_update_submitted_qc>March 11, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2011</last_update_posted>
  <keyword>AIDS-Related Opportunistic Infections</keyword>
  <keyword>Meningitis</keyword>
  <keyword>Injections, Intravenous</keyword>
  <keyword>Cryptococcosis</keyword>
  <keyword>Fluconazole</keyword>
  <keyword>Administration, Oral</keyword>
  <keyword>Acquired Immunodeficiency Syndrome</keyword>
  <keyword>Amphotericin B</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>Meningitis, Cryptococcal</mesh_term>
    <mesh_term>Meningitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluconazole</mesh_term>
    <mesh_term>Amphotericin B</mesh_term>
    <mesh_term>Liposomal amphotericin B</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

